Concepedia

Jorge DiMartino

JD

16

Publications

1.7K

Citations

14

H-Index

1988

Active since

Affiliations

University of California, San Francisco(Current)

South Texas Accelerated Research Therapeutics

Stanford University

University of Cincinnati

Cincinnati Children's Hospital Medical Center

Jorge DiMartino is an author at University of California, San Francisco specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1988–2021

16

Publications

16

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Eytan M. Stein, Guillermo Garcia‐Manero, David A. Rizzieri et al. · Blood · 2018 · 442 citations · Full text

Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia

Jun-Ping Wei, Mark Wunderlich, Catherine Fox et al. · Cancer Cell · 2008 · 318 citations · Full text

, , +10

The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver

Jorge DiMartino, Licia Selleri, David Traver et al. · Blood · 2001 · 172 citations · Full text

The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10

Jorge DiMartino, Paul M. Ayton, Everett H. Chen et al. · Blood · 2002 · 134 citations

A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL

Jorge DiMartino, T. R. Miller, Paul M. Ayton et al. · Blood · 2000 · 102 citations

Rows per page

1–5 of 16